Tetrahydrobiopterin Slows the Progression of Atherosclerosis

Articles in the same Issue

1. Serial Urinary Neopterin Measurements Reflect the Disease Course in Patients with Epithelial Ovarian Carcinoma Treated with Paclitaxel/Platinum Chemotherapy
2. Effects of Methanolic Extract and Commercial Oil of Nigella sativa L. on Blood Glucose and Antioxidant Capacity in Alloxan-Induced Diabetic Rats
3. Reference Standard of Serum Neopterin Concentration in Healthy Children
4. Systemic Immune Activation and Peripheral Blood Lymphocytes during Primary Chemotherapy with the Combination of Doxorubicin and Paclitaxel in Patients with Breast Carcinoma
5. Abstracts: 26th International Winter-Workshop on Clinical, Chemical, and Biochemical Aspects of Pteridines
6. Effect of Two Different Lighting Environments on Urinary Neopterin and Sulphatoxymelatonin in an Experimental Night Shift Model
7. A Basic Molecular Analysis of the Diabetic Antigen GAD by Homology Modelling. Principles of the Method and Understanding of Antigenicity and Binding Sites
8. Urinary Neopterin in Patients Treated with Gefitinib
9. In Vitro Effect of Neopterin on Splenic Mast Cell Development in Senescence Accelerated Mice (SAM)
10. A Modified Microbiological Method for Determination of Folate Levels in Erythrocyte and Plasma
11. Tetrahydrobiopterin Slows the Progression of Atherosclerosis
12. Plasma Total Homocysteine, Folate, and Vitamin B12 Status and Hospitalizations for Cardiovascular Disease
13. Urinary Neopterin in Patients with Diabetes Mellitus and Foot Ulcers
14. Neopterin, Catalase and Superoxide Dismutase in Females with Benign and Malignant Breast Tumors
15. Preliminary Evidence on the Direction of Effects Between Day-to-Day Changes in Cellular Immune Activation, Fatigue and Mood in a Patient with Prior Breast Cancer: A Time-Series Analysis Approach